This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $2,974.38 for the provision of pharmaceutical products and medical supplies to the Department of Defense's Medical Supply Chain. The contract has an ultimate completion date of May 10, 2024 and is a firm fixed price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $18,431.36 with a completion date of May 24, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to provide a wide range of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,446.46 to provide pharmaceutical products and medical supplies to the Medical Supply Chain, a component of the Department of Defense (DoD). The contract has a period of performance through July 10, 2024 and is a firm fixed-price arrangement. Amerisourcebergen has been awarded a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (Order) valued at $5,799.96. It was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and has a completion date of May 3, 2024. The Order is a Firm Fixed Price contract for the provision of pharmaceutical products and medical supplies, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $10,238.80 for the supply of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of April 30, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $1,446.66 for the provision of pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The contract, valued at $5,113.77, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is a delivery order valued at $1,716.78 with a completion date of May 6, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to provide a range of pharmaceutical products and medical supplies. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December...
This federal contract award, valued at $2,665.17, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for Prime Vendor Pharmaceutical Branch-Philadelphia, with a firm fixed price structure and an ultimate completion date of July 27, 2022. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,129.44 to provide pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. The order is placed under a larger single-award Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen...